Thrivent Financial for Lutherans
ZYME icon

Thrivent Financial for Lutherans’s Zymeworks ZYME Stock Holding History

Thrivent Financial for Lutherans’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-117,092
Closed -$919K – 2516
2022
Q4 		$919K Buy
117,092
+101,010
+628% +$710K ﹤0.01% 1781
2022
Q3 		$93K Buy
+16,082
New +$96.9K ﹤0.01% 2383
2022
Q1 		– Sell
-287,140
Closed -$4.71M – 2551
2021
Q4 		$4.71M Sell
287,140
-81,963
-22% -$1.71M 0.01% 916
2021
Q3 		$10.7M Buy
369,103
+46,739
+14% +$1.55M 0.02% 649
2021
Q2 		$11.2M Buy
322,364
+7,547
+2% +$239K 0.02% 643
2021
Q1 		$9.94M Buy
314,817
+70,085
+29% +$2.85M 0.02% 662
2020
Q4 		$11.6M Buy
244,732
+136,627
+126% +$6.34M 0.03% 602
2020
Q3 		$5.04M Buy
+108,105
New +$3.71M 0.01% 792

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Thrivent Financial for Lutherans's ZYME Position: Q1 2023 in Review

Thrivent Financial for Lutherans sold out of Zymeworks (ZYME) in Q1 2023, closing a stake of 117,092 shares — an estimated $919K sold.

Thrivent Financial for Lutherans first reported a position in ZYME in Q3 2020 and held it in 8 quarters. The position peaked at $11.6M in Q4 2020. 115 funds tracked by Wall St. Rank hold ZYME as of Q1 2023.

  • Thrivent Financial for Lutherans reported no remaining Zymeworks position as of Q1 2023 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 117,092 Zymeworks shares in Q1 2023, an estimated $919K.
  • Thrivent Financial for Lutherans first reported a position in Zymeworks in Q3 2020 and held it in 8 quarters.
  • Thrivent Financial for Lutherans's Zymeworks position peaked at $11.6M in Q4 2020.
  • 115 funds tracked by Wall St. Rank held Zymeworks as of Q1 2023.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2023, filed 17 May 2023.